Literature DB >> 21148232

Time interval to conversion of interferon-gamma release assay after exposure to tuberculosis.

S W Lee1, D K Oh, S H Lee, H Y Kang, C-T Lee, J-J Yim.   

Abstract

The proper interval for repeating an interferon-γ release assay (IGRA) among tuberculosis contacts with initially negative results is unknown. The interval for IGRA conversion after exposure to patients with active pulmonary tuberculosis in an outbreak setting was evaluated. In a platoon of 32 soldiers, four active pulmonary tuberculosis patients, in addition to one index patient, were diagnosed during a contact investigation. For the other 27 contacts, a tuberculin skin test (TST) and QuantiFERON® TB-Gold In-Tube (QFT-GIT) assay were performed. For soldiers with a negative result on the initial QFT-GIT assay, the test was repeated at 2, 4, 8, 14, 18 and 30 weeks until positive conversion occurred. When conversion was identified, the subject was treated for latent tuberculosis infection. Initially, 17 (63.0%) soldiers gave positive QFT-GIT results, whereas 21 (77.8%) showed positive TST results. Among 10 participants with initially negative QFT-GIT results, three showed conversion at 2 weeks, three at 4 weeks and three at 14 weeks. Conversion did not occur during the 30-week observation period in one contact. Based on the tuberculosis exposure time-points among the contacts, IGRA conversion generally occurred 4-7 weeks after exposure, although it could occur as late as 14-22 weeks after exposure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148232     DOI: 10.1183/09031936.00089510

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  18 in total

1.  Latent tuberculosis in healthcare workers: time to act.

Authors:  Issa Al Jahdhami
Journal:  Oman Med J       Date:  2013-03

Review 2.  Tuberculosis in the elderly: Why inflammation matters.

Authors:  Tucker J Piergallini; Joanne Turner
Journal:  Exp Gerontol       Date:  2017-12-26       Impact factor: 4.032

Review 3.  Immunology studies in non-human primate models of tuberculosis.

Authors:  JoAnne L Flynn; Hannah P Gideon; Joshua T Mattila; Philana Ling Lin
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

4.  Correlation between tuberculosis-specific interferon-γ release assay and intrathoracic calcification: A cross-sectional study.

Authors:  Izumi Yamatani; Kosaku Komiya; Hisayuki Shuto; Marimu Yamanaka; Mari Yamasue; Hiroki Yoshikawa; Kazufumi Hiramatsu; Jun-Ichi Kadota
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

5.  Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort.

Authors:  S W Lee; S H Lee; J-J Yim
Journal:  Infection       Date:  2012-05-15       Impact factor: 3.553

6.  Cough Aerosol Cultures of Mycobacterium tuberculosis: Insights on TST / IGRA Discordance and Transmission Dynamics.

Authors:  Edward C Jones-López; Laura F White; Bruce Kirenga; Francis Mumbowa; Martin Ssebidandi; Stephanie Moine; Olive Mbabazi; Gerald Mboowa; Irene Ayakaka; Soyeon Kim; Christina S Thornton; Alphonse Okwera; Moses Joloba; Kevin P Fennelly
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

7.  Tuberculin skin test and ELISPOT/T. SPOT.TB in children and adolescents with juvenile idiopathic arthritis.

Authors:  Flavio Sztajnbok; Neio L F Boechat; Samantha B Ribeiro; Sheila K F Oliveira; Denise C N Sztajnbok; Clemax C Sant'Anna
Journal:  Pediatr Rheumatol Online J       Date:  2014-05-22       Impact factor: 3.054

8.  Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.

Authors:  Denise F Johnson; LaShaunda L Malone; Sarah Zalwango; Joy Mukisa Oketcho; Keith A Chervenak; Bonnie Thiel; Harriet Mayanja-Kizza; Catherine M Stein; W Henry Boom; Christina L Lancioni
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

9.  Comparison of interferon-γ release assay to two cut-off points of tuberculin skin test to detect latent Mycobacterium tuberculosis infection in primary health care workers.

Authors:  Fernanda Mattos de Souza; Thiago Nascimento do Prado; Jair dos Santos Pinheiro; Renata Lyrio Peres; Thamy Carvalho Lacerda; Rafaela Borge Loureiro; Jose Américo Carvalho; Geisa Fregona; Elias Santos Dias; Lorrayne Beliqui Cosme; Rodrigo Ribeiro Rodrigues; Lee Wood Riley; Ethel Leonor Noia Maciel
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

10.  Tuberculin skin test distribution following a change in BCG vaccination policy.

Authors:  Sei Won Lee; Soo Yeon Oh; Jin Beom Lee; Chang Min Choi; Hee Jin Kim
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.